A PYMNTS Company

Canada: Pharmaceutical divestment forces conglomerate to revise financial outlook

By  |  March 31, 2013

A major Canadian conglomerate has announced its plans to divest its pharmaceutical company and sell the business to Kohl & Frisch Limited for between $80 million and $100 million. AmerisourceBergen Corporation will divest AmerisourceBergen Canada Corporation to the fulltime distributor in a deal that the parties expect to finalize in the year’s third fiscal quarter. ABCC represented about 2 percent of AmerisourceBergen’s total revenues; due to the transaction the company will reportedly revise its planned financial performance expectations.

 

Full Content: Fort Mill Times

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.